U.S. FDA decides to approve Moderna’s COVID-19 vaccine on emergency basis -FT

0
129
FILE PHOTO: A small shopping basket filled with vials labeled "COVID-19 - Coronavirus Vaccine" and a medical sryinge are placed on a Moderna logo in this illustration taken November 29, 2020. Picture taken November 29, 2020. REUTERS/Dado Ruvic/Ilustration

 (Reuters) – The U.S. Food and Drug Administration (FDA) decided on Thursday night to approve Moderna Inc’s coronavirus vaccine on an emergency basis, the Financial Times reported citing people close to the process.

The report comes after the FDA said it informed Moderna that it would rapidly work towards the finalization and issuance of emergency use authorization (EUA) for its COVID-19 vaccine candidate, according to commissioner Stephen Hahn.